<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39193369</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-1769</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in veterinary science</Title><ISOAbbreviation>Front Vet Sci</ISOAbbreviation></Journal><ArticleTitle>Flavonoids in mitigating the adverse effects of canine endotoxemia.</ArticleTitle><Pagination><StartPage>1396870</StartPage><MedlinePgn>1396870</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1396870</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fvets.2024.1396870</ELocationID><Abstract><AbstractText>In dogs, chronic enteropathies, and impaired gut integrity, as well as microbiome imbalances, are a major problem. These conditions may represent a continuous low endotoxin load, which may result in the development of diseases that are attributable to chronic inflammation. Flavonoids are polyphenolic plant compounds with numerous beneficial properties such as antioxidant, anti-inflammatory and antimicrobial effects. For our experiments, we isolated primary white blood cells (peripheral blood mononuclear cells and polymorphonuclear leukocytes) from healthy dogs and induced inflammation and oxidative stress with <i>Escherichia coli</i> and <i>Salmonella enterica</i> serovar Enteritidis lipopolysaccharide (LPS). In parallel, we treated the cell cultures with various flavonoids luteolin, quercetin and grape seed extract oligomeric proanthocyanidins (GSOP) alone and also in combination with LPS treatments. Then, changes in viability, reactive oxygen species (ROS) and tumor necrosis factor alpha (TNF-α) levels were measured in response to treatment with quercetin, luteolin and GSOP at 25 and 50 μg/mL concentrations. We found that ROS levels were significantly lower in groups which were treated by flavonoid and LPS at the same time compared to LPS-treated groups, whereas TNF-α levels were significantly reduced only by luteolin and quercetin treatment. In contrast, treatment with lower concentrations of GSOP caused an increase in TNF-α levels, while higher concentrations caused a significant decrease. These results suggest that the use of quercetin, luteolin and GSOP may be helpful in the management of chronic intestinal diseases in dogs with reduced intestinal barrier integrity or altered microbiome composition, or in the mitigation of chronic inflammatory processes maintained by endotoxemia. Further <i>in vitro</i> and <i>in vivo</i> studies are needed before clinical use.</AbstractText><CopyrightInformation>Copyright © 2024 Móritz, Kovács, Jerzsele, Psáder and Farkas.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Móritz</LastName><ForeName>Alma V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Veterinary Medicine, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, University of Veterinary Medicine, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovács</LastName><ForeName>Hédi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Veterinary Medicine, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jerzsele</LastName><ForeName>Ákos</ForeName><Initials>Á</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Veterinary Medicine, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, University of Veterinary Medicine, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Psáder</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Veterinary Medicine, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farkas</LastName><ForeName>Orsolya</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Veterinary Medicine, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Laboratory of Infectious Animal Diseases, Antimicrobial Resistance, Veterinary Public Health and Food Chain Safety, University of Veterinary Medicine, Budapest, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Vet Sci</MedlineTA><NlmUniqueID>101666658</NlmUniqueID><ISSNLinking>2297-1769</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PBMC</Keyword><Keyword MajorTopicYN="N">PMN</Keyword><Keyword MajorTopicYN="N">canine</Keyword><Keyword MajorTopicYN="N">cell culture</Keyword><Keyword MajorTopicYN="N">endotoxemia</Keyword><Keyword MajorTopicYN="N">flavonoids</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>4</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39193369</ArticleId><ArticleId IdType="pmc">PMC11347451</ArticleId><ArticleId IdType="doi">10.3389/fvets.2024.1396870</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karak P. Biological activities of flavonoids: an overview. Int J Pharm Sci Res. (2019) 10:1567–74. doi: 10.13040/IJPSR.0975-8232.10(4).1567-74</Citation><ArticleIdList><ArticleId IdType="doi">10.13040/IJPSR.0975-8232.10(4).1567-74</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasaly N, de Vos P, Hermoso MA. Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation. Front Immunol. (2021) 12:658354. doi: 10.3389/fimmu.2021.658354, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.658354</ArticleId><ArticleId IdType="pmc">PMC8187770</ArticleId><ArticleId IdType="pubmed">34122415</ArticleId></ArticleIdList></Reference><Reference><Citation>Wauquier F, Mevel E, Krisa S, Richard T, Valls J, Hornedo-Ortega R, et al. . Chondroprotective properties of human-enriched serum following polyphenol extract absorption: results from an exploratory clinical trial. Nutrients. (2019) 11:3071. doi: 10.3390/nu11123071, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11123071</ArticleId><ArticleId IdType="pmc">PMC6950735</ArticleId><ArticleId IdType="pubmed">31888255</ArticleId></ArticleIdList></Reference><Reference><Citation>Septembre-Malaterre A, Boumendjel A, Seteyen ALS, Boina C, Gasque P, Guiraud P, et al. . Focus on the high therapeutic potentials of quercetin and its derivatives. Phytomedicine Plus. (2022) 2:100220. doi: 10.1016/j.phyplu.2022.100220</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phyplu.2022.100220</ArticleId><ArticleId IdType="pmc">PMC8759805</ArticleId><ArticleId IdType="pubmed">35403087</ArticleId></ArticleIdList></Reference><Reference><Citation>Tekin İÖ, Marotta F. Chapter 22 - polyphenols and immune system. In: Watson RR, Preedy VR, Zibadi S, editors. Polyphenols: prevention and treatment of human disease (second edition) [internet]. Academic Press;  (2018). p. 263–76. Available at: https://www.sciencedirect.com/science/article/pii/B9780128130087000229</Citation></Reference><Reference><Citation>Coates PM, Paul MC, Blackman M, Blackman MR, Cragg GM, Levine M, et al. . Encyclopedia of dietary supplements (print). Boca Raton, Florida, USA: CRC Press; (2004).</Citation></Reference><Reference><Citation>Aghababaei F, Hadidi M. Recent advances in potential health benefits of quercetin. Pharmaceuticals. (2023) 16:1020. doi: 10.3390/ph16071020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph16071020</ArticleId><ArticleId IdType="pmc">PMC10384403</ArticleId><ArticleId IdType="pubmed">37513932</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahfoufi N, Alsadi N, Jambi M, Matar C. The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients. (2018) 10:1618. doi: 10.3390/nu10111618, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10111618</ArticleId><ArticleId IdType="pmc">PMC6266803</ArticleId><ArticleId IdType="pubmed">30400131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal N, Singh M, Singh SR. Flavonoids: food associations, therapeutic mechanisms, metabolism and nanoformulations. Food Res Int. (2022) 157:111442. doi: 10.1016/j.foodres.2022.111442, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2022.111442</ArticleId><ArticleId IdType="pubmed">35761682</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo DK, Heilmann RM, Paital B, Patel A, Yadav VK, Wong D, et al. . Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease. Front Endocrinol. (2023) 14:1217165. doi: 10.3389/fendo.2023.1217165</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1217165</ArticleId><ArticleId IdType="pmc">PMC10493311</ArticleId><ArticleId IdType="pubmed">37701897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasmi A, Mujawdiya PK, Lysiuk R, Shanaida M, Peana M, Gasmi Benahmed A, et al. . Quercetin in the prevention and treatment of coronavirus infections: a focus on SARS-CoV-2. Pharmaceuticals. (2022) 15:1049. doi: 10.3390/ph15091049, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15091049</ArticleId><ArticleId IdType="pmc">PMC9504481</ArticleId><ArticleId IdType="pubmed">36145270</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazeei Tabari MA, Iranpanah A, Bahramsoltani R, Rahimi R. Flavonoids as promising antiviral agents against SARS-CoV-2 infection: a mechanistic review. Molecules. (2021) 26:3900. doi: 10.3390/molecules26133900, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26133900</ArticleId><ArticleId IdType="pmc">PMC8271800</ArticleId><ArticleId IdType="pubmed">34202374</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie F, Yang W, Xing M, Zhang H, Ai L. Natural polyphenols-gut microbiota interactions and effects on glycolipid metabolism via polyphenols-gut-brain axis: a state-of-the-art review. Trends Food Sci Technol. (2023) 140:104171. doi: 10.1016/j.tifs.2023.104171</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2023.104171</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Fu K, Wang C, Ma C, Gong L, Zhou H, et al. . Protective effects of dietary quercetin on cerebral ischemic injury: pharmacology, pharmacokinetics and bioavailability-enhancing nanoformulations. Food Funct. (2023) 14:4470–89. doi: 10.1039/D2FO03122A, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2FO03122A</ArticleId><ArticleId IdType="pubmed">37067239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraz CR, Franciosi A, Emidio NB, Rasquel-Oliveira FS, Manchope MF, Carvalho TT, et al. . Chapter 15 - quercetin as an antiinflammatory analgesic In: Mushtaq M, Anwar F, editors. A centum of valuable plant bioactives: Academic Press;  (2021). 319–47. Available at:
https://www.sciencedirect.com/science/article/pii/B9780128229231000236</Citation></Reference><Reference><Citation>Deng Q, Li XX, Fang Y, Chen X, Xue J. Therapeutic potential of quercetin as an Antiatherosclerotic agent in atherosclerotic cardiovascular disease: a review. Evid Based Complement Alternat Med. (2020) 2020:e5926381: 1–12. doi: 10.1155/2020/5926381</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5926381</ArticleId><ArticleId IdType="pmc">PMC7292974</ArticleId><ArticleId IdType="pubmed">32565865</ArticleId></ArticleIdList></Reference><Reference><Citation>Daily JW, Kang S, Park S. Protection against Alzheimer’s disease by luteolin: role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis. Biofactors. (2021) 47:218–31. doi: 10.1002/biof.1703, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1703</ArticleId><ArticleId IdType="pubmed">33347668</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz N, Kim MY, Cho JY. Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies. J Ethnopharmacol. (2018) 225:342–58. doi: 10.1016/j.jep.2018.05.019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2018.05.019</ArticleId><ArticleId IdType="pubmed">29801717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Lazaro M. Distribution and biological activities of the flavonoid Luteolin. Mini Rev Med Chem. (2009) 9:31–59. doi: 10.2174/138955709787001712</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138955709787001712</ArticleId><ArticleId IdType="pubmed">19149659</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzoor MF, Ahmad N, Ahmed Z, Siddique R, Zeng XA, Rahaman A, et al. . Novel extraction techniques and pharmaceutical activities of luteolin and its derivatives. J Food Biochem. (2019) 43:e12974. doi: 10.1111/jfbc.12974</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jfbc.12974</ArticleId><ArticleId IdType="pubmed">31489656</ArticleId></ArticleIdList></Reference><Reference><Citation>Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, et al. . Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. (2019) 112:108612. doi: 10.1016/j.biopha.2019.108612</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.108612</ArticleId><ArticleId IdType="pubmed">30798142</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulaphisit M, Pomlok K, Saenjum C, Mungkornasawakul P, Trisuwan K, Wipasa J, et al. . The anti-leukemic activity of a luteolin-apigenin enriched fraction from an edible and ethnomedicinal plant, Elsholtzia stachyodes, is exerted through an ER stress/autophagy/cell cycle arrest/ apoptotic cell death signaling axis. Biomed Pharmacother. (2023) 160:114375. doi: 10.1016/j.biopha.2023.114375, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.114375</ArticleId><ArticleId IdType="pubmed">36753951</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelinger G, Merfort I, Schempp CM. Anti-oxidant, anti-inflammatory and anti-allergic activities of Luteolin. Planta Med. (2008) 74:1667–77. doi: 10.1055/s-0028-1088314, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0028-1088314</ArticleId><ArticleId IdType="pubmed">18937165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopalli SR, Annamneedi VP, Koppula S. Potential natural biomolecules targeting JAK/STAT/SOCS signaling in the management of atopic dermatitis. Molecules. (2022) 27:4660. doi: 10.3390/molecules27144660, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27144660</ArticleId><ArticleId IdType="pmc">PMC9319717</ArticleId><ArticleId IdType="pubmed">35889539</ArticleId></ArticleIdList></Reference><Reference><Citation>Beecher GR. Proanthocyanidins: biological activities associated with human health. Pharm Biol. (2004) 42:2–20. doi: 10.3109/13880200490893474</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13880200490893474</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallarès V, Fernández-Iglesias A, Cedó L, Castell-Auví A, Pinent M, Ardévol A, et al. . Grape seed procyanidin extract reduces the endotoxic effects induced by lipopolysaccharide in rats. Free Radic Biol Med. (2013) 60:107–14. doi: 10.1016/j.freeradbiomed.2013.02.007, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.02.007</ArticleId><ArticleId IdType="pubmed">23439188</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez-Pérez C, García-Villanova B, Guerra-Hernández E, Verardo V. Grape seeds Proanthocyanidins: an overview of in vivo bioactivity in animal models. Nutrients. (2019) 11:2435. doi: 10.3390/nu11102435, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11102435</ArticleId><ArticleId IdType="pmc">PMC6835351</ArticleId><ArticleId IdType="pubmed">31614852</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X, D’Souza DH. Grape seed extract for control of human enteric viruses. Appl Environ Microbiol. (2011) 77:3982–7. doi: 10.1128/AEM.00193-11, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.00193-11</ArticleId><ArticleId IdType="pmc">PMC3131668</ArticleId><ArticleId IdType="pubmed">21498749</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffei ME, Salata C, Gribaudo G. Tackling the future pandemics: broad-Spectrum antiviral agents (BSAAs) based on A-type Proanthocyanidins. Molecules. (2022) 27:8353. doi: 10.3390/molecules27238353, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27238353</ArticleId><ArticleId IdType="pmc">PMC9736452</ArticleId><ArticleId IdType="pubmed">36500445</ArticleId></ArticleIdList></Reference><Reference><Citation>Unusan N. Proanthocyanidins in grape seeds: an updated review of their health benefits and potential uses in the food industry. J Funct Foods. (2020) 67:103861. doi: 10.1016/j.jff.2020.103861</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2020.103861</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. (2013) 70:631–59. doi: 10.1007/s00018-012-1070-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-1070-x</ArticleId><ArticleId IdType="pmc">PMC11113843</ArticleId><ArticleId IdType="pubmed">22782113</ArticleId></ArticleIdList></Reference><Reference><Citation>Natividad JMM, Verdu EF. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res. (2013) 69:42–51. doi: 10.1016/j.phrs.2012.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2012.10.007</ArticleId><ArticleId IdType="pubmed">23089410</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporali S, De Stefano A, Calabrese C, Giovannelli A, Pieri M, Savini I, et al. . Anti-inflammatory and active biological properties of the plant-derived bioactive compounds Luteolin and Luteolin 7-glucoside. Nutrients. (2022) 14:1155. doi: 10.3390/nu14061155, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14061155</ArticleId><ArticleId IdType="pmc">PMC8949538</ArticleId><ArticleId IdType="pubmed">35334812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesjak M, Beara I, Simin N, Pintać D, Majkić T, Bekvalac K, et al. . Antioxidant and anti-inflammatory activities of quercetin and its derivatives. J Funct Foods. (2018) 40:68–75. doi: 10.1016/j.jff.2017.10.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2017.10.047</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimoi K, Okada H, Furugori M, Goda T, Takase S, Suzuki M, et al. . Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett. (1998) 438:220–4. doi: 10.1016/S0014-5793(98)01304-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(98)01304-0</ArticleId><ArticleId IdType="pubmed">9827549</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Ruaux C, Griebsch C, Boland L, Wong N, Bennett P, et al. . Serum proteome of dogs with chronic enteropathy. J Vet Intern Med. (2023) 37:925–35. doi: 10.1111/jvim.16682, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim.16682</ArticleId><ArticleId IdType="pmc">PMC10229361</ArticleId><ArticleId IdType="pubmed">37186013</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandrieux JRS, Mansfield CS. Chronic enteropathy in canines: prevalence, impact and management strategies. Vet Med. (2019) 10:203–14. doi: 10.2147/VMRR.S162774, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VMRR.S162774</ArticleId><ArticleId IdType="pmc">PMC6902862</ArticleId><ArticleId IdType="pubmed">31828025</ArticleId></ArticleIdList></Reference><Reference><Citation>Matei-Latiu MC, Andrei S, Victoria B, Cernea M, Dumitras DA, Daniela Mihaela N, et al. . Evaluation of ENDOTOXEMIA, soluble CD14 and IL-1Β in dogs with intestinal DYSBIOSIS that were treated with probiotics: a prospective study. Farmacia. (2021) 69:1153–8. doi: 10.31925/farmacia.2021.6.20</Citation><ArticleIdList><ArticleId IdType="doi">10.31925/farmacia.2021.6.20</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerquetella M, Rossi G, Suchodolski JS, Schmitz SS, Allenspach K, Rodríguez-Franco F, et al. . Proposal for rational antibacterial use in the diagnosis and treatment of dogs with chronic diarrhoea. J Small Anim Pract. (2020) 61:211–5. doi: 10.1111/jsap.13122, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsap.13122</ArticleId><ArticleId IdType="pmc">PMC7079140</ArticleId><ArticleId IdType="pubmed">32065388</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson KW, Jergens AE. Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease. Vet Clin North Am Small Anim Pract. (2011) 41:381–98. doi: 10.1016/j.cvsm.2011.02.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvsm.2011.02.003</ArticleId><ArticleId IdType="pubmed">21486642</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Ding F, Di W, Lv Y, Xia F, Sheng Y, et al. . Impact of a high-fat diet on intestinal stem cells and epithelial barrier function in middle-aged female mice. Mol Med Rep. (2020) 21:1133–44. doi: 10.3892/mmr.2020.10932, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.10932</ArticleId><ArticleId IdType="pmc">PMC7003032</ArticleId><ArticleId IdType="pubmed">32016468</ArticleId></ArticleIdList></Reference><Reference><Citation>Schauf S, de la Fuente G, Newbold CJ, Salas-Mani A, Torre C, Abecia L, et al. . Effect of dietary fat to starch content on fecal microbiota composition and activity in dogs1. J Anim Sci. (2018) 96:3684–98. doi: 10.1093/jas/sky264, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jas/sky264</ArticleId><ArticleId IdType="pmc">PMC6127775</ArticleId><ArticleId IdType="pubmed">30060077</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q, Li XX, Fang Y, Chen X, Xue J. Association of Obesity with serum leptin, adiponectin, and serotonin and gut microflora in beagle dogs. J Vet Intern Med. (2015) 29:43–50. doi: 10.1111/jvim.12455, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim.12455</ArticleId><ArticleId IdType="pmc">PMC4858068</ArticleId><ArticleId IdType="pubmed">25407880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieler IN, Shamzir Kamal S, Vitger AD, Nielsen DS, Lauridsen C, Bjornvad CR. Gut microbiota composition may relate to weight loss rate in obese pet dogs. Vet Med Sci. (2017) 3:252–62. doi: 10.1002/vms3.80, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/vms3.80</ArticleId><ArticleId IdType="pmc">PMC5677773</ArticleId><ArticleId IdType="pubmed">29152318</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya-Alonso JA, Bautista-Castaño I, Peña C, Suárez L, Juste MC, Tvarijonaviciute A. Prevalence of canine obesity, obesity-related metabolic dysfunction, and relationship with owner obesity in an obesogenic region of Spain. Front Vet Sci. (2017) 4:59. doi: 10.3389/fvets.2017.00059, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2017.00059</ArticleId><ArticleId IdType="pmc">PMC5403824</ArticleId><ArticleId IdType="pubmed">28487859</ArticleId></ArticleIdList></Reference><Reference><Citation>Cave N, Delaney SJ, Larsen JA. Nutritional management of gastrointestinal diseases In: Fascetti AJ, Delaney SJ, Larsen JA, Villaverde C, editors. Applied veterinary clinical nutrition: John Wiley &amp; Sons, Ltd; (2023). 235–98.</Citation></Reference><Reference><Citation>Nagao I, Ambrosini Y. High-fat diet enhances stemness and compromises intestinal permeability in a translational canine intestinal organoid model. (2023). Available at:
https://www.researchsquare.com/article/rs-3287136/v1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11059635</ArticleId><ArticleId IdType="pubmed">38689222</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Pan Z, Yang R, Bi Y, Xiong X. The canine gastrointestinal microbiota: early studies and research frontiers. Gut Microbes. (2020) 11:635–54. doi: 10.1080/19490976.2019.1704142</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2019.1704142</ArticleId><ArticleId IdType="pmc">PMC7524387</ArticleId><ArticleId IdType="pubmed">31992112</ArticleId></ArticleIdList></Reference><Reference><Citation>Grześkowiak Ł, Endo A, Beasley S, Salminen S. Microbiota and probiotics in canine and feline welfare. Anaerobe. (2015) 34:14–23. doi: 10.1016/j.anaerobe.2015.04.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anaerobe.2015.04.002</ArticleId><ArticleId IdType="pmc">PMC7111060</ArticleId><ArticleId IdType="pubmed">25863311</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchodolski JS, Markel ME, Garcia-Mazcorro JF, Unterer S, Heilmann RM, Dowd SE, et al. . The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLoS One. (2012) 7:e51907. doi: 10.1371/journal.pone.0051907, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051907</ArticleId><ArticleId IdType="pmc">PMC3530590</ArticleId><ArticleId IdType="pubmed">23300577</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho LP, Kultima JR, Costea PI, Fournier C, Pan Y, Czarnecki-Maulden G, et al. . Similarity of the dog and human gut microbiomes in gene content and response to diet. Microbiome. (2018) 6:72. doi: 10.1186/s40168-018-0450-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-018-0450-3</ArticleId><ArticleId IdType="pmc">PMC5907387</ArticleId><ArticleId IdType="pubmed">29669589</ArticleId></ArticleIdList></Reference><Reference><Citation>Minamoto Y, Otoni CC, Steelman SM, Büyükleblebici O, Steiner JM, Jergens AE, et al. . Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease. Gut Microbes. (2015) 6:33–47. doi: 10.1080/19490976.2014.997612, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2014.997612</ArticleId><ArticleId IdType="pmc">PMC4615558</ArticleId><ArticleId IdType="pubmed">25531678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez J, Rhimi S, Kriaa A, Mariaule V, Boudaya H, Drut A, et al. . Domestic environment and gut microbiota: lessons from pet dogs. Microorganisms. (2022) 10:949. doi: 10.3390/microorganisms10050949, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10050949</ArticleId><ArticleId IdType="pmc">PMC9143008</ArticleId><ArticleId IdType="pubmed">35630391</ArticleId></ArticleIdList></Reference><Reference><Citation>Dye TL, Diehl KJ, Wheeler SL, Westfall DS. Randomized, controlled trial of budesonide and prednisone for the treatment of idiopathic inflammatory bowel disease in dogs. J Vet Intern Med. (2013) 27:1385–91. doi: 10.1111/jvim.12195, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim.12195</ArticleId><ArticleId IdType="pubmed">24112400</ArticleId></ArticleIdList></Reference><Reference><Citation>Craven M, Simpson JW, Ridyard AE, Chandler ML. Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J Small Anim Pract. (2004) 45:336–42. doi: 10.1111/j.1748-5827.2004.tb00245.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-5827.2004.tb00245.x</ArticleId><ArticleId IdType="pubmed">15266855</ArticleId></ArticleIdList></Reference><Reference><Citation>White R, Atherly T, Guard B, Rossi G, Wang C, Mosher C, et al. . Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease. Gut Microbes. (2017) 8:451–66. doi: 10.1080/19490976.2017.1334754, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2017.1334754</ArticleId><ArticleId IdType="pmc">PMC5628651</ArticleId><ArticleId IdType="pubmed">28678609</ArticleId></ArticleIdList></Reference><Reference><Citation>Alessandri G, Milani C, Mancabelli L, Mangifesta M, Lugli GA, Viappiani A, et al. . Metagenomic dissection of the canine gut microbiota: insights into taxonomic, metabolic and nutritional features. Environ Microbiol. (2019) 21:1331–43. doi: 10.1111/1462-2920.14540, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1462-2920.14540</ArticleId><ArticleId IdType="pubmed">30680877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu T, Liu G, Zhang H, Wang L, Zhou S, Dou H, et al. . Changes in feeding habits promoted the differentiation of the composition and function of gut microbiotas between domestic dogs (Canis lupus familiaris) and gray wolves (Canis lupus). AMB Express. (2018) 8:123. doi: 10.1186/s13568-018-0652-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13568-018-0652-x</ArticleId><ArticleId IdType="pmc">PMC6072643</ArticleId><ArticleId IdType="pubmed">30073560</ArticleId></ArticleIdList></Reference><Reference><Citation>Matei MC, Andrei SM, Buza V, Cernea MS, Dumitras DA, Neagu D, et al. . Natural Endotoxemia in dogs—a hidden condition that can be treated with a potential probiotic containing Bacillus subtilis, Bacillus licheniformis and Pediococcus acidilactici: a study model. Animals. (2021) 11:1367. doi: 10.3390/ani11051367, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ani11051367</ArticleId><ArticleId IdType="pmc">PMC8150349</ArticleId><ArticleId IdType="pubmed">34064947</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampath V. Bacterial endotoxin-lipopolysaccharide; structure, function and its role in immunity in vertebrates and invertebrates. Agric Nat Resour. (2018) 52:115–20. doi: 10.1016/j.anres.2018.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anres.2018.08.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y, Yang Y, Wu Z. Programming of metabolic and autoimmune diseases in canine and feline: linkage to the gut microbiome. Microb Pathog. (2023) 185:106436. doi: 10.1016/j.micpath.2023.106436, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2023.106436</ArticleId><ArticleId IdType="pubmed">37913827</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol. (2021) 11:594150. doi: 10.3389/fimmu.2020.594150, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.594150</ArticleId><ArticleId IdType="pmc">PMC7829348</ArticleId><ArticleId IdType="pubmed">33505393</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi G, Gavazza A, Vincenzetti S, Mangiaterra S, Galosi L, Marchegiani A, et al. . Clinicopathological and fecal proteome evaluations in 16 dogs presenting chronic diarrhea associated with Lymphangiectasia. Vet Sci. (2021) 8:242. doi: 10.3390/vetsci8100242</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vetsci8100242</ArticleId><ArticleId IdType="pmc">PMC8537460</ArticleId><ArticleId IdType="pubmed">34679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Jergens AE, Guard BC, Redfern A, Rossi G, Mochel JP, Pilla R, et al. . Microbiota-related changes in unconjugated fecal bile acids are associated with naturally occurring, insulin-dependent diabetes mellitus in dogs. Front Vet Sci. (2019) 6:199. doi: 10.3389/fvets.2019.00199, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2019.00199</ArticleId><ArticleId IdType="pmc">PMC6610424</ArticleId><ArticleId IdType="pubmed">31316997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G. Anticancer effects of the microbiome and its products. Nat Rev Microbiol. (2017) 15:465–78. doi: 10.1038/nrmicro.2017.44</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.44</ArticleId><ArticleId IdType="pubmed">28529325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Zhang Y, Yang H, Rao Y, Miao J, Lu X. Intestinal microbiota as an alternative therapeutic target for epilepsy. Can J Infect Dis Med Microbiol. (2016) 2016:9032809–6. doi: 10.1155/2016/9032809, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/9032809</ArticleId><ArticleId IdType="pmc">PMC5108868</ArticleId><ArticleId IdType="pubmed">27882059</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y, Hsu ACY, Zuo X, Guo X, Zhou Z, Jiang S, et al. . Chronic exposure to low-level lipopolysaccharide dampens influenza-mediated inflammatory response via A20 and PPAR network. Front Immunol. (2023) 14:1119473. doi: 10.3389/fimmu.2023.1119473, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1119473</ArticleId><ArticleId IdType="pmc">PMC9886269</ArticleId><ArticleId IdType="pubmed">36726689</ArticleId></ArticleIdList></Reference><Reference><Citation>Neethi Raj P, Shaji BV, Haritha VH, Anie Y. Neutrophil secretion modulates neutrophil and monocyte functions during hyperglucose and/or hyperinsulin conditions in vitro. J Cell Immunother. (2018) 4:65–70. doi: 10.1016/j.jocit.2018.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocit.2018.02.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilla R, Suchodolski JS. The role of the canine gut microbiome and metabolome in health and gastrointestinal disease. Front Vet Sci. (2020) 6:498. doi: 10.3389/fvets.2019.00498, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2019.00498</ArticleId><ArticleId IdType="pmc">PMC6971114</ArticleId><ArticleId IdType="pubmed">31993446</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlanda M, Innocente G, Simionati B, Di Camillo B, Facchin S, Giron MC, et al. . Faecal microbiome transplantation as a solution to chronic enteropathies in dogs: a case study of beneficial microbial evolution. Animals. (2021) 11:1433. doi: 10.3390/ani11051433, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ani11051433</ArticleId><ArticleId IdType="pmc">PMC8156139</ArticleId><ArticleId IdType="pubmed">34067662</ArticleId></ArticleIdList></Reference><Reference><Citation>English D, Andersen BR. Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods. (1974) 5:249–52. doi: 10.1016/0022-1759(74)90109-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(74)90109-4</ArticleId><ArticleId IdType="pubmed">4427075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovács D, Karancsi Z, Farkas O, Jerzsele Á. Antioxidant activity of flavonoids in LPS-treated IPEC-J2 porcine intestinal epithelial cells and their antibacterial effect against Bacteria of swine origin. Antioxidants. (2020) 9:1267. doi: 10.3390/antiox9121267, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9121267</ArticleId><ArticleId IdType="pmc">PMC7764120</ArticleId><ArticleId IdType="pubmed">33322114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovács D, Palkovicsné Pézsa N, Móritz AV, Jerzsele Á, Farkas O. Effects of Luteolin in an in vitro model of porcine intestinal infections. Animals. (2024) 14:1952. doi: 10.3390/ani14131952, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ani14131952</ArticleId><ArticleId IdType="pmc">PMC11240391</ArticleId><ArticleId IdType="pubmed">38998064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirivibulkovit K, Nouanthavong S, Sameenoi Y. Paper-based DPPH assay for antioxidant activity analysis. Anal Sci. (2018) 34:795–800. doi: 10.2116/analsci.18P014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2116/analsci.18P014</ArticleId><ArticleId IdType="pubmed">29998961</ArticleId></ArticleIdList></Reference><Reference><Citation>Apak R. Current Issues in Antioxidant Measurement. J Agric Food Chem. (2019) 67:9187–202. doi: 10.1021/acs.jafc.9b03657</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.9b03657</ArticleId><ArticleId IdType="pubmed">31259552</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchodolski JS. Intestinal microbiota of dogs and cats: a bigger world than we thought. Vet Clin N Am Small Anim Pract. (2011) 41:261–72. doi: 10.1016/j.cvsm.2010.12.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvsm.2010.12.006</ArticleId><ArticleId IdType="pmc">PMC7132526</ArticleId><ArticleId IdType="pubmed">21486635</ArticleId></ArticleIdList></Reference><Reference><Citation>Honneffer JB, Minamoto Y, Suchodolski JS. Microbiota alterations in acute and chronic gastrointestinal inflammation of cats and dogs. World J Gastroenterol. (2014) 20:16489–97. doi: 10.3748/wjg.v20.i44.16489, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i44.16489</ArticleId><ArticleId IdType="pmc">PMC4248192</ArticleId><ArticleId IdType="pubmed">25469017</ArticleId></ArticleIdList></Reference><Reference><Citation>Thumann TA, Pferschy-Wenzig EM, Moissl-Eichinger C, Bauer R. The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders. J Ethnopharmacol. (2019) 245:112153. doi: 10.1016/j.jep.2019.112153, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2019.112153</ArticleId><ArticleId IdType="pubmed">31408679</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathee P, Chaudhary H, Rathee S, Rathee D, Kumar V, Kohli K. Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm Allergy Drug Targets. (2009) 8:229–35. doi: 10.2174/187152809788681029</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152809788681029</ArticleId><ArticleId IdType="pubmed">19601883</ArticleId></ArticleIdList></Reference><Reference><Citation>Md Idris MH, Amin S, Amin S, Nyokat N, Khong HY, Selvaraj M, et al. . Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies. Beni-Suef Univ J Basic Appl Sci. (2022) 11:117. doi: 10.1186/s43088-022-00296-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43088-022-00296-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Śmiechowicz J. The rationale and current status of endotoxin adsorption in the treatment of septic shock. J Clin Med. (2022) 11:619. doi: 10.3390/jcm11030619</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030619</ArticleId><ArticleId IdType="pmc">PMC8836955</ArticleId><ArticleId IdType="pubmed">35160068</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo DK, Borcherding DC, Chandra L, Jergens AE, Atherly T, Bourgois-Mochel A, et al. . Differential transcriptomic profiles following stimulation with lipopolysaccharide in intestinal organoids from dogs with inflammatory bowel disease and intestinal mast cell tumor. Cancers. (2022) 14:3525. doi: 10.3390/cancers14143525, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14143525</ArticleId><ArticleId IdType="pmc">PMC9322748</ArticleId><ArticleId IdType="pubmed">35884586</ArticleId></ArticleIdList></Reference><Reference><Citation>Tráj P, Sebők C, Mackei M, Kemény Á, Farkas O, Kákonyi Á, et al. . Luteolin: a phytochemical to mitigate S. typhimurium Flagellin-induced inflammation in a chicken in vitro hepatic model. Animals. (2023) 13:1410. doi: 10.3390/ani13081410, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ani13081410</ArticleId><ArticleId IdType="pmc">PMC10135145</ArticleId><ArticleId IdType="pubmed">37106972</ArticleId></ArticleIdList></Reference><Reference><Citation>Procházková D, Boušová I, Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. (2011) 82:513–23. doi: 10.1016/j.fitote.2011.01.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fitote.2011.01.018</ArticleId><ArticleId IdType="pubmed">21277359</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltanian A, Mosallanejad B, Jalali M, Najafzadeh H, Ghorbanpoor M. The therapeutic effects of quercetin in a canine model of low-dose lipopolysaccharide-induced Sepsis compared with hydrocortisone. Iranian J Vet Med. (2019) 13:377–87. doi: 10.22059/ijvm.2019.260871.1004910</Citation><ArticleIdList><ArticleId IdType="doi">10.22059/ijvm.2019.260871.1004910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleiveland CR. Peripheral blood mononuclear cells In: Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, et al., editors. The impact of food bioactives on health: in vitro and ex vivo models [internet]. Cham: Springer;  (2015) Available at:
http://www.ncbi.nlm.nih.gov/books/NBK500157/</Citation><ArticleIdList><ArticleId IdType="pubmed">29787039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SY, An JH, Kim KB, Lee JH, Park SM, Oh Y, et al. . Gene expression of adipokines and inflammatory cytokines in peripheral blood mononuclear cells of obese dogs. Vet Med Sci. (2022) 8:517–23. doi: 10.1002/vms3.713, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/vms3.713</ArticleId><ArticleId IdType="pmc">PMC8959286</ArticleId><ArticleId IdType="pubmed">35044092</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskowska AK, Wilczak A, Skowrońska W, Michel P, Melzig MF, Czerwińska ME. Fruits of Hippophaë rhamnoides in human leukocytes and Caco-2 cell monolayer models—a question about their preventive role in lipopolysaccharide leakage and cytokine secretion in endotoxemia. Front Pharmacol. (2022) 13:981874. doi: 10.3389/fphar.2022.981874, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.981874</ArticleId><ArticleId IdType="pmc">PMC9561609</ArticleId><ArticleId IdType="pubmed">36249809</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang KL, Yu SJ, Huang WC, Yen HR. Luteolin attenuates allergic nasal inflammation via inhibition of Interleukin-4 in an allergic rhinitis mouse model and peripheral blood from human subjects with allergic rhinitis. Front Pharmacol. (2020) 11:291. doi: 10.3389/fphar.2020.00291, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00291</ArticleId><ArticleId IdType="pmc">PMC7093717</ArticleId><ArticleId IdType="pubmed">32256362</ArticleId></ArticleIdList></Reference><Reference><Citation>Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther. (2001) 296:181–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11123379</ArticleId></ArticleIdList></Reference><Reference><Citation>Siard MH, McMurry KE, Adams AA. Effects of polyphenols including curcuminoids, resveratrol, quercetin, pterostilbene, and hydroxypterostilbene on lymphocyte pro-inflammatory cytokine production of senior horses in vitro. Vet Immunol Immunopathol. (2016) 173:50–9. doi: 10.1016/j.vetimm.2016.04.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2016.04.001</ArticleId><ArticleId IdType="pubmed">27090627</ArticleId></ArticleIdList></Reference><Reference><Citation>Chedea VS, Braicu C, Socaciu C. Antioxidant/prooxidant activity of a polyphenolic grape seed extract. Food Chem. (2010) 121:132–9. doi: 10.1016/j.foodchem.2009.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2009.12.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao TK, Powell J, de Water JV, Keen CL, Schmitz HH, Hammerstone JF, et al. . The effect of cocoa procyanidins on the transcription and secretion of interleukin 1β in peripheral blood mononuclear cells. Life Sci. (2000) 66:1377–86. doi: 10.1016/S0024-3205(00)00449-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0024-3205(00)00449-5</ArticleId><ArticleId IdType="pubmed">11210713</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JC, Lee SH, Hong JK, Cho JH, Kim IH, Park SK. Effect of dietary supplementation of Procyanidin on growth performance and immune response in pigs. Asian Australas J Anim Sci. (2014) 27:131–9. doi: 10.5713/ajas.2013.13359, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.5713/ajas.2013.13359</ArticleId><ArticleId IdType="pmc">PMC4093277</ArticleId><ArticleId IdType="pubmed">25049935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol. (1993) 151:6853–61. doi: 10.4049/jimmunol.151.12.6853</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.151.12.6853</ArticleId><ArticleId IdType="pubmed">8258695</ArticleId></ArticleIdList></Reference><Reference><Citation>Karancsi Z, Kovács D, Palkovicsné Pézsa N, Gálfi P, Jerzsele Á, Farkas O. The impact of quercetin and its methylated derivatives 3-o-Methylquercetin and Rhamnazin in lipopolysaccharide-induced inflammation in porcine intestinal cells. Antioxidants. (2022) 11:1265. doi: 10.3390/antiox11071265, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11071265</ArticleId><ArticleId IdType="pmc">PMC9312192</ArticleId><ArticleId IdType="pubmed">35883756</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouamama S, Bouamama A. Quercetin handles cellular oxidant/antioxidant systems and mitigates immunosenescence hallmarks in human PBMCs: an in vitro study. J Biochem Mol Toxicol. (2023) 37:e23354. doi: 10.1002/jbt.23354</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbt.23354</ArticleId><ArticleId IdType="pubmed">36988281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Lin JM, Li XS, Li J. Quercetin ameliorates LPS-induced inflammation in human peripheral blood mononuclear cells by inhibition of the TLR2-NF-κB pathway. Genet Mol Res. (2016) 15:1–9. doi: 10.4238/gmr.15028297</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/gmr.15028297</ArticleId><ArticleId IdType="pubmed">27421015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Mo R, Wang H, Liu T, Zhang G, Wu Y. Grape seed proanthocyanidin improves intestinal inflammation in canine through regulating gut microbiota and bile acid compositions. FASEB J. (2023) 37:e23285. doi: 10.1096/fj.202300819RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202300819RR</ArticleId><ArticleId IdType="pubmed">37933950</ArticleId></ArticleIdList></Reference><Reference><Citation>Thilakarathna SH, Rupasinghe HPV. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients. (2013) 5:3367–87. doi: 10.3390/nu5093367, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu5093367</ArticleId><ArticleId IdType="pmc">PMC3798909</ArticleId><ArticleId IdType="pubmed">23989753</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>